xanthenes has been researched along with Atherosclerotic Parkinsonism in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrade, PB; Guedes-Dias, P; Leitão-Rocha, A; Oliveira, JM; Pinho, BR; Quintas, C; Reis, SD; Santos, MM; Valentão, P | 1 |
| Kondo, K; Matsumura, K; Okuda, Y; Takahashi, Y; Yamamoto, T | 1 |
| Degkwitz, R | 1 |
| Kingstone, E; Kolivakis, T; Kossatz, I | 1 |
| Bertuzzi, F; Dogliani, P; Senini, G | 1 |
1 review(s) available for xanthenes and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
[l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
Topics: Acetylcholine; Basal Ganglia; Butyrophenones; Chorea; Dihydroxyphenylalanine; Dopamine; Extrapyramidal Tracts; Humans; Methyldopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Parkinson Disease, Secondary; Phenothiazines; Reserpine; Tranquilizing Agents; Xanthenes | 1969 |
1 trial(s) available for xanthenes and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Double blind study of clopenthixol and chlorpromazine in acute hospitalized schizophrenics.
Topics: Acute Disease; Adolescent; Adult; Aged; Aspartate Aminotransferases; Blood Pressure; Body Weight; Chlorpromazine; Clinical Trials as Topic; Female; Humans; Liver Function Tests; Male; Middle Aged; Parkinson Disease, Secondary; Perphenazine; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Vision Disorders; Xanthenes; Xerostomia | 1970 |
3 other study(ies) available for xanthenes and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Behavior, Animal; Benzamides; Diencephalon; Disease Models, Animal; Histone Deacetylase 1; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Histone Deacetylases; Hydroxamic Acids; Indoles; Larva; Locomotion; Neurotoxins; Oxazines; Parkinson Disease, Secondary; Pyridines; RNA, Messenger; Tyrosine 3-Monooxygenase; Xanthenes; Zebrafish; Zebrafish Proteins | 2016 |
[Treatment of Parkinsonism with Tremarial (SJ-1977)].
Topics: Adolescent; Adult; Atropine; Female; Humans; Male; Middle Aged; Parasympatholytics; Parkinson Disease; Parkinson Disease, Secondary; Phenothiazines; Piperidines; Schizophrenia; Xanthenes | 1967 |
Clinical observations on the therapeutic activity of flupentixol in the treatment of chronic schizophrenia.
Topics: Adult; Aged; Blood; Body Weight; Chlorpromazine; Chronic Disease; Delusions; Depression, Chemical; Female; Hallucinations; Humans; Hypnotics and Sedatives; Male; Middle Aged; Orphenadrine; Parkinson Disease, Secondary; Piperazines; Psychomotor Disorders; Psychopharmacology; Schizophrenia; Social Behavior; Stimulation, Chemical; Transaminases; Xanthenes | 1970 |